The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals

Background: The use of readily available biochemical investigations to predict the CD4 cell count in HIV-infected patients may provide clinicians with insight regarding disease severity at first contact. The aims of the study were to determine the relationship of calculated globulin and white cell c...

Full description

Bibliographic Details
Main Authors: Yusuf Moolla, Zaheer Moolla, Tarylee Reddy, Nombulelo Magula
Format: Article
Language:English
Published: AOSIS 2015-09-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/4306
_version_ 1797987958431678464
author Yusuf Moolla
Zaheer Moolla
Tarylee Reddy
Nombulelo Magula
author_facet Yusuf Moolla
Zaheer Moolla
Tarylee Reddy
Nombulelo Magula
author_sort Yusuf Moolla
collection DOAJ
description Background: The use of readily available biochemical investigations to predict the CD4 cell count in HIV-infected patients may provide clinicians with insight regarding disease severity at first contact. The aims of the study were to determine the relationship of calculated globulin and white cell count (WCC) with CD4 cell count. Methods: Data were collected prospectively from ambulatory HIV-infected, anti-retro viral therapy (ART) naive patients at the HIV clinic of King Edward Hospital, Durban, between 2010 and 2012. Results: The mean age of the participants was 39 ± 9.53 years and 70% were female. Median calculated globulin and WCC was 49 g/l and 4.74 × 109 cells/l respectively, whilst the CD4 cell count was 244 cells/mm3. A significant positive correlation was demonstrated between CD4 cell count and WCC (r = 0.25, p 0.001). WCC and albumin were identified as potential surrogate markers for CD4 count ≤ 200 cells/mm3. Combination of WCC with either albumin or globulin predicts a CD4 count of less than 200 cells/ mm3 with moderate accuracy. Conclusion: The use of combined biomarkers may influence initiation of Pneumocystis jiroveci pneumonia prophylaxis in resource-limited settings. Further evaluation is warranted to assess the role of these markers in disease progression and ART.
first_indexed 2024-04-11T07:56:25Z
format Article
id doaj.art-de6e70b8cbab40299486cc38bd2f3d60
institution Directory Open Access Journal
issn 2078-6190
2078-6204
language English
last_indexed 2024-04-11T07:56:25Z
publishDate 2015-09-01
publisher AOSIS
record_format Article
series South African Family Practice
spelling doaj.art-de6e70b8cbab40299486cc38bd2f3d602022-12-22T04:35:55ZengAOSISSouth African Family Practice2078-61902078-62042015-09-0157510.4102/safp.v57i5.43063530The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individualsYusuf Moolla0Zaheer Moolla1Tarylee Reddy2Nombulelo Magula3Department of Internal Medicine, Addington Hospital, Durban, South Africa; and Department of Internal Medicine, University of KwaZulu-Natal, DurbanDepartment of General Surgery, Addington Hospital, DurbanMedical Research Council, Biostatistics Unit, DurbanDepartment of Internal Medicine, University of KwaZulu-Natal, DurbanBackground: The use of readily available biochemical investigations to predict the CD4 cell count in HIV-infected patients may provide clinicians with insight regarding disease severity at first contact. The aims of the study were to determine the relationship of calculated globulin and white cell count (WCC) with CD4 cell count. Methods: Data were collected prospectively from ambulatory HIV-infected, anti-retro viral therapy (ART) naive patients at the HIV clinic of King Edward Hospital, Durban, between 2010 and 2012. Results: The mean age of the participants was 39 ± 9.53 years and 70% were female. Median calculated globulin and WCC was 49 g/l and 4.74 × 109 cells/l respectively, whilst the CD4 cell count was 244 cells/mm3. A significant positive correlation was demonstrated between CD4 cell count and WCC (r = 0.25, p 0.001). WCC and albumin were identified as potential surrogate markers for CD4 count ≤ 200 cells/mm3. Combination of WCC with either albumin or globulin predicts a CD4 count of less than 200 cells/ mm3 with moderate accuracy. Conclusion: The use of combined biomarkers may influence initiation of Pneumocystis jiroveci pneumonia prophylaxis in resource-limited settings. Further evaluation is warranted to assess the role of these markers in disease progression and ART.https://safpj.co.za/index.php/safpj/article/view/4306albumincalculated globulincd4 cell counthiv infectionwhite cell count
spellingShingle Yusuf Moolla
Zaheer Moolla
Tarylee Reddy
Nombulelo Magula
The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals
South African Family Practice
albumin
calculated globulin
cd4 cell count
hiv infection
white cell count
title The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals
title_full The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals
title_fullStr The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals
title_full_unstemmed The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals
title_short The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals
title_sort use of readily available biomarkers to predict cd4 cell counts in hiv infected individuals
topic albumin
calculated globulin
cd4 cell count
hiv infection
white cell count
url https://safpj.co.za/index.php/safpj/article/view/4306
work_keys_str_mv AT yusufmoolla theuseofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals
AT zaheermoolla theuseofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals
AT taryleereddy theuseofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals
AT nombulelomagula theuseofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals
AT yusufmoolla useofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals
AT zaheermoolla useofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals
AT taryleereddy useofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals
AT nombulelomagula useofreadilyavailablebiomarkerstopredictcd4cellcountsinhivinfectedindividuals